Oral fructose absorption in obese children with non-alcoholic fatty liver disease

Area of Science:

• Pediatric Gastroenterology and Hepatology
• Metabolic Disorders
• Nutritional Science

Background:

• Fructose consumption is a known risk factor for developing non-alcoholic fatty liver disease (NAFLD).
• Understanding fructose metabolism is crucial for managing pediatric NAFLD.
• This study investigates differences in fructose handling in children with and without NAFLD.

Purpose of the Study:

• To quantify and compare the absorption and metabolic processing of fructose in children diagnosed with NAFLD.
• To evaluate these parameters against those in both obese and lean control groups.
• To identify potential metabolic alterations related to fructose in pediatric NAFLD.

Main Methods:

• A cohort of children with confirmed NAFLD, along with obese and lean controls, ingested a standardized oral fructose dose.
• Serum and urine samples were collected at intervals up to 360 minutes post-ingestion to measure glucose, insulin, uric acid, and fructose levels.
• Breath hydrogen levels were also monitored as an indicator of carbohydrate absorption.

Main Results:

• Children with NAFLD exhibited higher serum glucose, insulin, and uric acid levels compared to lean controls post-fructose intake.
• NAFLD patients showed significantly lower urinary fructose excretion and breath hydrogen production compared to lean controls.
• When compared to obese controls, NAFLD patients had elevated serum uric acid and reduced urinary fructose excretion, with similar glucose, insulin, and breath hydrogen responses.

Conclusions:

• Children diagnosed with NAFLD demonstrate a more efficient absorption and metabolism of fructose compared to their lean counterparts.
• This enhanced fructose processing in pediatric NAFLD is associated with a more pronounced adverse metabolic response following fructose ingestion.
• Findings suggest altered fructose metabolism contributes to the pathophysiology of NAFLD in children.